|
|
||||||||
Ann Thorac Surg 1997;63:835-837
© 1997 The Society of Thoracic Surgeons
Divisions of Thoracic and Cardiovascular Surgery and Pediatric Cardiology, University of Louisville School of Medicine, Louisville, Kentucky
Accepted for publication October 9, 1996.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A 2-day-old female neonate was referred for treatment. She was the 3.4-kg product of an uneventful pregnancy and normal spontaneous vaginal delivery. Apgar scores were 8 and 9 at 1 and 5 minutes, and she was stable for the first 12 hours of life. Feeding intolerance then developed, accompanied by progressive tachypnea, tachycardia, groaning, and increasing cyanosis, and she was transferred emergently to our institution.
On admission, the child had a respiratory rate of 72/min, a heart rate of 156 beats/min, temperature of 38.2°C, and blood pressure of 63/43 mm Hg. She was dusky and had petechiae over the head and neck. Distal pulses were weak and capillary refill was delayed at 3 seconds. No cardiac murmurs were appreciated. The initial arterial blood gas measurement is seen in Table 1
(measurement 1). Emergency intubation was performed, and a repeat arterial blood gas measurement was performed on ventilator settings of inspired oxygen concentration of 0.30, IMV 5, and positive inspiratory pressure/positive end-expiratory pressure of 18/4 mm Hg (measurement 2). Intravenous prostaglandin E1 (0.1 µg·kg-1·min-1) administration was started. Early on the morning of the first hospital day the patient's blood pressure decreased to 37/31 mm Hg, and a dopamine infusion was started at 10 µg·kg-1·min-1. Due to persistent hypotension, the dopamine dose was soon increased to 20 µg·kg-1·min-1, and dobutamine (20 µg·kg-1·min-1) administration was started. Arterial blood gas measurements were obtained after the hypotensive episode (measurement 3).
|
Over the 3 days following admission, the patient had recurrent hemodynamic and respiratory instability, including a sudden respiratory decompensation on the second hospital day. At this time her heart rate decreased to 45 beats/min, her arterial oxygen saturation fell to 23%, and her systolic blood pressure was 40 mm Hg. Her hemodynamics and saturations slowly improved, and Carbair (21% O2, 5% CO2) was introduced into the ventilator circuit at a rate of 1 L/min. On hospital day 3 the patient had another respiratory decompensation, requiring hand ventilation, during which she was poorly responsive and showed signs of compromised perfusion. Throughout this period the patient required doses of dopamine and dobutamine of 20 µg·kg-1·min-1.
In an attempt to improve the management of the patient's hemodynamic status, on hospital day 4 we placed a 4F oximetric catheter (Abbott Biomedical, North Chicago, IL) via the umbilical vein and positioned its tip in the midportion of the inferior vena cava. Continuous monitoring of SvO2s was started. Before catheter placement, arterial saturation was 71%, and an arterial blood gas measurement was taken (measurement 4). Venous oxygen saturation at this point was only 37% (measurement 5).
A number of interventions were then performed with the aim of increasing SvO2. The rate of Carbair administration was first increased to 3 L/min, and the dopamine infusion was decreased to 14 µg·kg-1·min-1. Dobutamine administration was decreased to 16 µg·kg-1·min-1. Each intervention had the effect of increasing SvO2 incrementally, and after supplemental N2 was added to lower the inspired oxygen fraction to 0.17 on hospital day 5, SvO2 finally increased to 59%. Measurement of arterial blood gases showed no base deficit (measurement 6). Systolic blood pressure ranged from 65 to 86 mm Hg.
With the patient hemodynamically more stable, a repeat echocardiogram showed substantial improvement in tricuspid valvular function, with only mild (1+) regurgitation. Accordingly, the decision was made to proceed with operative intervention. Before the operation, the patient was able to be weaned to continuous positive airway pressure and then extubated, with a systemic arterial oxygen saturation (SaO2) of 84% and SvO2 of 70% on room air. Just before the operation, the patient had her dose of dopamine decreased to 11 µg·kg-1·min-1 and her dose of dobutamine decreased to 14 µg·kg-1·min-1.
The patient underwent first-stage palliation (Norwood procedure). A 3.5-mm polytetrafluoroethylene modified Blalock-Taussig shunt was placed. Pulmonary homograft tissue was used to augment the aortic arch. Intraoperative epicardial echocardiography showed mild (1+) tricuspid regurgitation off bypass.
The oximetric catheter was left in place for initial postoperative management. The patient had a steady recovery. Cardiac catheterization before discharge revealed good ventricular function, an unobstructed aortic arch, and mild (1+) tricuspid valve regurgitation.
| Comment |
|---|
|
|
|---|
Diligent attempts to "balance" the pulmonary and systemic circulations appear to be met with some improvement in survival [3]. Unfortunately, there are few easily obtainable measurements to indicate when this balance has been achieved. Some of the more easily obtained bedside measurements, such as SaO2, may not reflect an "unbalanced" flow ratio until the infant is extremely unstable. Rossi and associates [4] recently described a number of instances in which patients having an adequate SaO2 progressed to rapid decompensation and even death. These patients likely had an excessively high pulmonary-to-systemic flow ratio (QP/QS ratio), which maintained adequate pulmonary flow, as reflected in an elevated SaO2, but produced inadequate systemic flow to sustain end-organ function.
Although it has been suggested that obtaining "ideal" blood gas levels, defined as a pH of about 7.4, carbon dioxide tension of 35 to 40 mm Hg, and oxygen tension of about 40 mm Hg, reflects a balanced QP/QS ratio [5], it is possible to have optimal arterial blood gas levels and still have unbalanced flows. The present case demonstrates this with our patient having an arterial pH of 7.42, carbon dioxide tension of 36 mm Hg, and oxygen tension of 34 mm Hg and still having an SvO2 of only 37%, implying that there was an excessively high QP/QS ratio. Conversely, arterial blood gases with an arterial oxygen tension greater than 40 mm Hg do not necessarily imply excessive pulmonary flow.
Accordingly, we have recently used both a computer model and an animal model of the univentricular circulation to try to find measurements that would more accurately reflect the patient's clinical status and the balance of flows in the systemic and pulmonary circulations [6]. This research suggested that SvO2 is a good marker for both the QP/QS ratio and oxygen delivery. When SvO2 is maximized, a QP/QS ratio that produces optimal oxygen delivery has been reached.
Prompted by these results, we have been following SvO2 via placement of an oximetric catheter in our patients with the hypoplastic left heart syndrome. We have found the data that the catheters provide are extremely useful, as is clearly demonstrated in the present case. Persistent decreased SvO2s, even in the face of adequate SaO2 and arterial blood gases, alert us to situations in which an excessive QP/QS ratio may be leading to clinical instability but has not yet affected the SaO2, thus allowing for earlier intervention. Continuous monitoring gives us immediate feedback regarding the effectiveness of interventions. By choosing therapeutic maneuvers aimed at increasing SvO2, we have been able to ameliorate the clinical status of a number of unstable infants, the most dramatic instance being the case reported here. It is our hope that wider application of this approach may lead to improved outcomes for children born with these difficult defects.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. A. Guzzetta Phenoxybenzamine in the Treatment of Hypoplastic Left Heart Syndrome: A Core Review Anesth. Analg., August 1, 2007; 105(2): 312 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, E. A. Stuth, R. D. B. Jaquis, and S. Berger Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 738 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Drinkwater Jr, A. S. Aharon, S. V. Quisling, D. Dodd, V. S. Reddy, A. Kavanaugh-McHugh, T. Doyle, N. R. Patel, F. E. Barr, J. K. Kambam, et al. Modified Norwood operation for hypoplastic left heart syndrome Ann. Thorac. Surg., December 1, 2001; 72(6): 2081 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, J. M. Simsic, and A. M. Atz Hemodynamic effects of inspired carbon dioxide after the Norwood procedure Ann. Thorac. Surg., December 1, 2001; 72(6): 2088 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tabbutt, C. Ramamoorthy, L. M. Montenegro, S. M. Durning, C. D. Kurth, J. M. Steven, R. I. Godinez, T. L. Spray, G. Wernovsky, and S. C. Nicolson Impact of Inspired Gas Mixtures on Preoperative Infants With Hypoplastic Left Heart Syndrome During Controlled Ventilation Circulation, September 18, 2001; 104 (2009): I-159 - I-164. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, N. S. Ghanayem, J. M. Kampine, S. Berger, K. A. Mussatto, S. B. Litwin, and J. S. Tweddell Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome Ann. Thorac. Surg., November 1, 2000; 70(5): 1515 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rychik, D. M. Bush, T. L. Spray, J. W. Gaynor, and G. Wernovsky Assessment of pulmonary/systemic blood flow ratio after first-stage palliation for hypoplastic left heart syndromeDevelopment of a new index with the use of doppler echocardiography J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, G. M. Hoffman, R. T. Fedderly, N. S. Ghanayem, J. M. Kampine, S. Berger, K. A. Mussatto, and S. B. Litwin Patients at risk for low systemic oxygen delivery after the Norwood procedure Ann. Thorac. Surg., June 1, 2000; 69(6): 1893 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, G. M. Hoffman, R. T. Fedderly, S. Berger, J. P. Thomas Jr, N. S. Ghanayem, M. W. Kessel, and S. B. Litwin Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure Ann. Thorac. Surg., January 1, 1999; 67(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |